Related Experiment Video

Updated: Jul 18, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

New insights into p53 regulation and gene therapy for cancer

A G Zeimet1, K Riha, J Berger

  • 1Department of Obstetrics and Gynecology, University Hospital, Innsbruck, Austria. alain.zeimet@uibk.ac.at

Biochemical Pharmacology
|September 29, 2000
PubMed

Insights

Restoring the tumor suppressor p53 function via gene therapy shows promise for cancer treatment. Adenoviral delivery targets cancer cells, but optimizing viral entry is key to enhancing therapeutic efficiency and patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The transcription factor p53 is a critical tumor suppressor involved in cell cycle control and apoptosis.
  • TP53 mutations are frequent in human cancers, highlighting its role in malignant transformation.
  • Restoring p53 function is a key strategy for cancer gene therapy.

Purpose of the Study:

  • To investigate the potential of adenoviral-based p53 gene therapy for cancer treatment.
  • To identify the rate-limiting steps in adenoviral gene delivery for therapeutic efficiency.
  • To explore combination strategies to enhance the effectiveness of p53 gene therapy.

Main Methods:

  • Adenoviral vectors for p53 gene transfection.
  • Analysis of viral cell entry mechanisms, including receptor-mediated attachment and integrin interactions.
  • Evaluation of p53 restoration in combination with apoptosis-inducing agents and anti-apoptotic signal neutralizers.

Main Results:

  • Adenoviral-based p53 gene therapy is under clinical investigation.
  • Viral cell entry is the rate-limiting step for gene delivery and therapeutic efficacy.
  • The role of p53 restoration in enhancing tumor response to cytostatic agents is under debate.

Conclusions:

  • Adenoviral-based p53 gene therapy is a promising approach for cancer treatment.
  • Optimizing viral cell entry is crucial for improving gene delivery efficiency.
  • Combining p53 gene therapy with other pro-apoptotic agents or anti-apoptotic therapies may enhance treatment outcomes.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...